Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;14(1):57–63. doi: 10.1016/0168-1702(89)90069-5

Inhibition of murine coronavirus RNA synthesis by hydroxyguanidine derivatives

James G Keck 1,∗, Wang Pou-Hsiung 2, Eric J Lien 2, Michael MC Lai 1
PMCID: PMC7133932  PMID: 2554614

Abstract

A series of hydroxyguanidine derivatives, which are substituted salicylaldehyde Schiff-bases of 1-amino-3- hydroxyguanidine tosylate, were tested for the inhibition of RNA synthesis of mouse hepatitis virus (MHV). It was shown that these compounds could selectively inhibit virus-specific RNA synthesis. Every aspect of viral RNA synthesis, including synthesis of negative-stranded RNA, subgenomic mRNA transcription and genomic RNA replication, was inhibited to roughly the same extent. These compounds are the first known inhibitors of coronaviral RNA synthesis and should prove useful for understanding the mechanism of viral RNA synthesis.

Keywords: Mouse hepatitis virus, Coronavirus

References

  1. Baric R.S., Stohlman S.A., Lai M.M.C. Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J. Virol. 1983;48:633–640. doi: 10.1128/jvi.48.3.633-640.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baric R.S., Stohlman S.A., Razavi M.K., Lai M.M.C. Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res. 1985;3:19–33. doi: 10.1016/0168-1702(85)90038-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brayton P.R., Lai M.M.C., Patton C.D., Stohlman S.A. Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J. Virol. 1982;42:847–853. doi: 10.1128/jvi.42.3.847-853.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brayton P.R., Stohlman S.A., Lai M.M.C. Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology. 1984;133:197–201. doi: 10.1016/0042-6822(84)90439-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caliguiri L.A., Tamm I. Guanidine. In: Bauer D.J., editor. Vol. 1. Pergamon Press; Oxford, New York, Toronto: 1972. pp. 181–230. (Chemotherapy of Virus Diseases). [Google Scholar]
  6. Hirano N., Fujiwara K., Hino S., Matsumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Ges. Virusforsch. 1974;44:298–302. doi: 10.1007/BF01240618. [DOI] [PubMed] [Google Scholar]
  7. Keck J.G., Hogue B.G., Brian D.A., Lai M.M.C. Temporal regulation of bovine coronavirus RNA synthesis. Virus Res. 1988;9:343–356. doi: 10.1016/0168-1702(88)90093-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lai M.M.C. Coronavirus leader-RNA-primed transcription: an alternative mechanism to RNA splicing. Bioessays. 1987;5:257–260. doi: 10.1002/bies.950050606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lai M.M.C., Brayton P.R., Armen R.C., Patton C.D., Pugh C., Stohlman S.A. Mouse hepatitis virus A59: messenger RNA structure and genetic localization of the sequence divergence from the hepatotropic strain MHV3. J. Virol. 1981;39:823–834. doi: 10.1128/jvi.39.3.823-834.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lai M.M.C., Patton C.D., Stohlman S.A. Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genomic length. J. Virol. 1982;44:487–492. doi: 10.1128/jvi.44.2.487-492.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Leibowitz J.L., DeVries F.R., Haspel M.V. Genetic analysis of murine hepatitis virus strain JHM. J. Virol. 1982;42:1080–1087. doi: 10.1128/jvi.42.3.1080-1087.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Makino S., Keck J.G., Stohlman S.A., Lai M.M.C. High frequency RNA recombination of murine coronavirus. J. Virol. 1986;56:729–737. doi: 10.1128/jvi.57.3.729-737.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Makino S., Stohlman S.A., Lai M.M.C. Vol. 83. 1986. Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of the free leader RNA in transcription; pp. 4204–4208. (Proc. Natl. Acad. Sci., USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pincus S.E., Diamond D.C., Emini E.A., Wimmer E. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 1986;57:638–646. doi: 10.1128/jvi.57.2.638-646.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shieh C.-K., Soe L.H., Makino S., Chang M.-F., Stohlman S.A., Lai M.M.C. The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology. 1987;156:321–330. doi: 10.1016/0042-6822(87)90412-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sturman L.S., Holmes K.V. The molecular biology of coronavirus. Adv. Virus Res. 1983;28:35–112. doi: 10.1016/S0065-3527(08)60721-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tershak D.K. Inhibition of poliovirus polymerase by guanidine in vitro. J. Virol. 1982;41:313–318. doi: 10.1128/jvi.41.1.313-318.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]

Articles from Virus Research are provided here courtesy of Elsevier

RESOURCES